Abstract
In late 2019, coronavirus-2 (SARS-COV 2) infection emerged in Wuhan, China and spread to all countries making the first pandemic of the 21st century. It seems that this infection will persist which is long enough to obligate modifications in both lifestyle and health care systems. Because chronic liver diseases (CLD) are prevalent all over the world, it is expected to manage patients with CLD and COVID-19. The aim of this review was to shed light on the impact of COVID-19 pandemic on the management of patients with CLD and how to give medical care to CLD patients during COVID-19 pandemic.
Keywords: Coronavirus disease, COVID-19, pandemic, chronic liver diseases, cirrhosis, HCC.
Infectious Disorders - Drug Targets
Title:Modifications of Medical Care of Chronic Liver Diseases During COVID-19 Pandemic: Necessity or Novelty?
Volume: 21 Issue: 8
Author(s): Hanan Hamed Soliman, Mohamed H. Emara, Mahmoud Elkadeem and Sherief Abd-Elsalam*
Affiliation:
- Tropical Medicine and Infectious Diseases Department, Faculty of Medicine, Tanta University,Egypt
Keywords: Coronavirus disease, COVID-19, pandemic, chronic liver diseases, cirrhosis, HCC.
Abstract: In late 2019, coronavirus-2 (SARS-COV 2) infection emerged in Wuhan, China and spread to all countries making the first pandemic of the 21st century. It seems that this infection will persist which is long enough to obligate modifications in both lifestyle and health care systems. Because chronic liver diseases (CLD) are prevalent all over the world, it is expected to manage patients with CLD and COVID-19. The aim of this review was to shed light on the impact of COVID-19 pandemic on the management of patients with CLD and how to give medical care to CLD patients during COVID-19 pandemic.
Export Options
About this article
Cite this article as:
Soliman Hamed Hanan , Emara H. Mohamed , Elkadeem Mahmoud and Abd-Elsalam Sherief*, Modifications of Medical Care of Chronic Liver Diseases During COVID-19 Pandemic: Necessity or Novelty?, Infectious Disorders - Drug Targets 2021; 21 (8) : e160921189886 . https://dx.doi.org/10.2174/1871526520666210104152256
DOI https://dx.doi.org/10.2174/1871526520666210104152256 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Comparison of Intra and Post-operative Sedation Efficacy of Dexmedetomidinemidazolam
and Dexmedetomidine-propofol for Major Abdominal Surgery
Current Drug Metabolism Editorial
Current Pediatric Reviews Protease-Activated Receptor-2 Antagonists and Agonists
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Synthesis, Physico-Chemical Properties and DFT Calculations of New 2-(4- Arylpiperazine-1-yl)-1-(3-ethylbenzofuran-2-yl)ethanols As Potential Antihypertensive Agents
Current Organic Chemistry Oxytocin in the Heart Regeneration
Recent Patents on Cardiovascular Drug Discovery Adrenomedullin Expression in Alzheimer's Brain
Current Alzheimer Research Phenomenology and Neurobiology of Childhood Onset Schizophrenia
Current Psychiatry Reviews Cancer Treatment-Induced Cardiotoxicity: a Cardiac Stem Cell Disease?
Cardiovascular & Hematological Agents in Medicinal Chemistry Anti-Oxidant Gene Therapy by NFkB Decoy Oligodeoxynucleotide
Current Pharmaceutical Biotechnology Cardiovascular Effects of Hypoglycemic Agents in Diabetes Mellitus
Current Drug Safety Molecularly Imprinted Polymers for Selective Solid-Phase Extraction of Verapamil from Biological Fluids and Human Urine
Current Pharmaceutical Analysis Stress as a Pathophysiological Factor in Functional Somatic Syndromes
Current Psychiatry Reviews Pyrazolo-Triazolo-Pyrimidine Derivatives as Adenosine Receptor Antagonists: A Possible Template for Adenosine Receptor Subtypes?
Current Pharmaceutical Design Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for the Treatment of Chronic Lymphocytic Leukemia
Current Drug Therapy Genetics and Personalized Medicine in Antidepressant Treatment
Current Pharmaceutical Design Aldosterone to Renin Ratio (ARR) in Clinical use, with Reference to the Primary Care Setting: ARR to Whom, When, How, What for?
Current Hypertension Reviews Erythropoietin in Stroke Therapy: Friend or Foe
Current Medicinal Chemistry Mobile Phone Text Message Interventions in Psychiatry - What are the Possibilities?
Current Psychiatry Reviews Prevalence and Risk Factors of Vitamin D Deficiency in Critically Ill Patients
Inflammation & Allergy - Drug Targets (Discontinued) Amniotic Fluid Embolism: What Level of Scientific Evidence can be Drawn? A Systematic Review
Current Pharmaceutical Biotechnology